Buildit, Paul and others, am I wrong here? When / if

New Post Public Reply Private Reply Replies (1) Message Board
hylander Buildit #21669
340
Buildit, Paul and others, am I wrong here?

When / if NGIO gets listed say in October, even if the PPS for Generex is let's just say .10, it won't really matter, because if NGIO is at 4.00 or 6.00 PPS, then the PPS of Generex would rise accordingly based off of the value it has in NGIO based on it's own stock, correct?

So, you would see it dramatically go up anyways.

So, could we be seeing someone(s) purchasing a ton of stock in anticipation of this happening now as we get closer to a listing. Because the PPS of Generex should rise quite a bit.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 10

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 9

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 8

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 14

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Cartier Faces Class Action Suit Over Warranty Practices

Updated Category News Views 801

Overview of the Class Action Lawsuit Against Cartier A class action lawsuit is currently drawing attention from both consumers and legal experts due to serious allegations against the luxury jewelry brand, Cartier. The lawsuit, initiated by Plaintiff Daniel J. Voelker, was filed recently and focuses on claims that Cartier has failed to honor written warranties for certain...

Continue Reading
Revolutionizing Hotel Sales: Canary Technologies' New Hub

Updated Category News Views 160

Revolutionizing Hotel Sales with AI Technology Canary Technologies has launched an innovative Sales & Catering Payments Hub that empowers hotel teams to manage and close contracts more efficiently. This groundbreaking platform allows Sales & Catering teams to expedite their processes and ensure they receive payments smoothly. Streamlining Hotel Operations for Greater...

Continue Reading
Exploring The RealReal's Current Growth and Future Potential

Updated Category News Views 192

Understanding The Surge of The RealReal Inc. The RealReal Inc. (NASDAQ: REAL) has gained significant attention recently, with its stock rallying over 35% following a favorable earnings report. This surge appears to reflect underlying structural changes within the company, raising questions about the momentum and what it signifies for the future of the stock. The Cakra...

Continue Reading
Silly Nice Expands Reach: Now in 60 NY Dispensaries

Updated Category News Views 53

Silly Nice Expands Across New York's Dispensaries In less than four months since its launch, Silly Nice, a Black and Veteran-owned cannabis brand, has significantly transformed its presence in the New York cannabis market. Now available in more than 60 dispensaries across the state, Silly Nice is thriving thanks to its commitment to quality products and community...

Continue Reading
Aker ASA Set to Announce Financial Results and Future Outlook

Updated Category News Views 124

Aker ASA Set to Reveal Third Quarter Financial Results OSLO, Norway — Aker ASA is excited to announce the publication of its financial results for the third quarter of 2025. The highly anticipated event is scheduled for a Tuesday morning presentation on November 4, 2025. The financial results will be available at 07:00 CET, providing stakeholders with crucial insights...

Continue Reading